100 related articles for article (PubMed ID: 32253809)
21. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
[TBL] [Abstract][Full Text] [Related]
22. Late-onset Huntington disease with intermediate CAG repeats: true or false?
Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
[TBL] [Abstract][Full Text] [Related]
23. Exploring the correlates of intermediate CAG repeats in Huntington disease.
Ha AD; Jankovic J
Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
[TBL] [Abstract][Full Text] [Related]
24. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
[TBL] [Abstract][Full Text] [Related]
25. Author response: Huntington disease reduced penetrance alleles occur at high frequency in the general population.
Hayden MR; Kay C
Neurology; 2017 Jan; 88(3):334-335. PubMed ID: 28093515
[No Abstract] [Full Text] [Related]
26. Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population.
Jankovic J; Squitieri F
Neurology; 2017 Jan; 88(3):334. PubMed ID: 28093514
[No Abstract] [Full Text] [Related]
27. Huntington Disease: Molecular Diagnostics Approach.
Bastepe M; Xin W
Curr Protoc Hum Genet; 2015 Oct; 87():9.26.1-9.26.23. PubMed ID: 26439718
[TBL] [Abstract][Full Text] [Related]
28. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
29. Triplet repeat primed PCR simplifies testing for Huntington disease.
Jama M; Millson A; Miller CE; Lyon E
J Mol Diagn; 2013 Mar; 15(2):255-62. PubMed ID: 23414820
[TBL] [Abstract][Full Text] [Related]
30. Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms.
Hećimović S; Klepac N; Vlasić J; Vojta A; Janko D; Skarpa-Prpić I; Canki-Klain N; Marković D; Bozikov J; Relja M; Pavelić K
Hum Mutat; 2002 Sep; 20(3):233. PubMed ID: 12204002
[TBL] [Abstract][Full Text] [Related]
31. Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results.
Semaka A; Hayden MR
Clin Genet; 2014 Apr; 85(4):303-11. PubMed ID: 24256063
[TBL] [Abstract][Full Text] [Related]
32. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease.
Maat-Kievit A; Helderman-van den Enden P; Losekoot M; de Knijff P; Belfroid R; Vegter-van der Vlis M; Roos R; Breuning M
Am J Med Genet; 2001 Dec; 105(8):737-44. PubMed ID: 11803522
[TBL] [Abstract][Full Text] [Related]
33. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population.
Alonso ME; Yescas P; Cisneros B; Martínez C; Silva G; Ochoa A; Montañez C
Clin Genet; 1997 Apr; 51(4):225-30. PubMed ID: 9184242
[TBL] [Abstract][Full Text] [Related]
35. The Danish HD Registry-a nationwide family registry of HD families in Denmark.
Gilling M; Budtz-Jørgensen E; Boonen SE; Lildballe D; Bojesen A; Hertz JM; Sørensen SA
Clin Genet; 2017 Sep; 92(3):338-341. PubMed ID: 28155235
[TBL] [Abstract][Full Text] [Related]
36. Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.
Larson E; Fyfe I; Morton AJ; Monckton DG
Neurobiol Dis; 2015 Apr; 76():98-111. PubMed ID: 25662336
[TBL] [Abstract][Full Text] [Related]
37. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.
Kremer B; Almqvist E; Theilmann J; Spence N; Telenius H; Goldberg YP; Hayden MR
Am J Hum Genet; 1995 Aug; 57(2):343-50. PubMed ID: 7668260
[TBL] [Abstract][Full Text] [Related]
38. Single-step scalable-throughput molecular screening for Huntington disease.
Teo CR; Wang W; Yang Law H; Lee CG; Chong SS
Clin Chem; 2008 Jun; 54(6):964-72. PubMed ID: 18403567
[TBL] [Abstract][Full Text] [Related]
39. Clinical and genetic data of Huntington disease in Moroccan patients.
Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis: low frequency of DF508 mutation in 2 population samples from Rio de Janeiro, Brazil.
Cabello GM; Moreira AF; Horovitz D; Correia P; Santa Rosa A; Llerena J; Greg J; Grody WW; Degrave WM; Fernandes O; Cabello PH
Hum Biol; 1999 Apr; 71(2):189-96. PubMed ID: 10222642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
